Dr. Schatter cites a paper by Dr. Patricia Steeg of the National Cancer Institute (NCI) that calls out an “alarming” but debatable decline in survival in other advanced cancers and a general lack of progress against metastatic disease. But Dr. Schatter focuses (here) on the "bright side" by offering as evidence these graphs of median survival (left) and 5-year relative survival (right) after an initial diagnosis of metastatic breast cancer.
|Graphs based on information provided by the NCI Cancer Surveillance Branch (May, 2016), based on SEER 11 data. Click on image for an enlarged view.|
I interviewed Lynn on May 2, 2016, and the eyeforpharma Philadelphia conference. Click on "Read mor >>" to see the interview.